News Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University...
Page Polsky Council The Polsky Council comprises many of the country’s leading entrepreneurs, venture capitalists, and private equity investors, who provide ongoing guidance and support to the Polsky Center.
Technology Senolytic Therapeutics To Eliminate Senescent Cells And Enhance Aging And Cancer Treatments Targeted approach to remove aging, disease-related, or chemotherapy/immunotherapy-induced senescent cells while sparing healthy cells The Unmet Need: Approaches to selectively eliminate senescent cells improving aging symptoms without damaging healthy…
News U of C Startup Seurat Therapeutics Announces $510K in Grant Funding Seurat Therapeutics, Inc. is a University of Chicago startup biotech company developing a nasal spray to treat and prevent migraines
Technology Self-assembling Nanofibril Particles for Controlled Release of IV and SUBQ Therapeutics Clinically approved methods for the controlled release of oral therapies have demonstrated their efficacy in reducing required dosage, administration frequency, and side effects, thereby boosting patient compliance. Despite these successes,…
Technology Endothelium-Targeted mRNA Therapeutics For Acute And Chronic Vascular Disease Targeted delivery of therapeutic mRNA to inflamed vascular endothelial cells, achieving localized reduction of vascular inflammation and arterial plaque formation to improve treatment outcomes in arterial diseases by using VCAM1-directed…
Page 2025 Companies Traditional // Rayni ($835,000) Hestus ($350,000) Lumina AI ($250,000) Bera ($220,000) MycoWorks Health ($175,000) Vantage Robotics ($150,000) Clover Labs ($110,000) Veyda ($75,000) Northline Energy ($52,000) Synova ($50,000) College // Exactics...
News Innovation Fund Invests $575,000 in Biotech Companies The University of Chicago Innovation Fund announced plans to invest up to $575,000 into three biotechnology companies—ImmunArtes, Onchilles Pharma, and Oxalo Therapeutics. These latest investments bring the Innovation Fund’s total...
News RiMO Therapeutics Announces Enrollment of the First Patient in Phase 1 Study of RiMO-301 with Radiation in Advanced Tumors
News Alnair Therapeutics Follows Polsky Path to String of Impressive Wins, $1M+ Funding Round Momentum continues to build for Alnair Therapeutics, an oncology startup focused on developing a platform to better deliver drugs to hard-to-treat cancers. In June – the same month that the...
